These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11594443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
    Kuoppamäki M, Seppälä T, Syvälahti E, Hietala J.
    Eur J Pharmacol; 1994 Oct 14; 269(2):201-8. PubMed ID: 7851496
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR.
    J Neurochem; 1999 May 14; 72(5):2127-34. PubMed ID: 10217294
    [Abstract] [Full Text] [Related]

  • 6. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
    Andersen K, Liljefors T, Hyttel J, Perregaard J.
    J Med Chem; 1996 Sep 13; 39(19):3723-38. PubMed ID: 8809161
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
    Syvälahti E, Penttilä J, Majasuo H, Pälvimäki EP, Laakso A, Hietala J.
    Pharmacopsychiatry; 2006 Jan 13; 39(1):1-8. PubMed ID: 16453246
    [Abstract] [Full Text] [Related]

  • 8. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
    Rosenzweig-Lipson S, Zhang J, Mazandarani H, Harrison BL, Sabb A, Sabalski J, Stack G, Welmaker G, Barrett JE, Dunlop J.
    Brain Res; 2006 Feb 16; 1073-1074():240-51. PubMed ID: 16430874
    [Abstract] [Full Text] [Related]

  • 9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A.
    Assay Drug Dev Technol; 2005 Dec 16; 3(6):649-59. PubMed ID: 16438660
    [Abstract] [Full Text] [Related]

  • 10. Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo.
    Navailles S, De Deurwaerdère P, Spampinato U.
    Biol Psychiatry; 2006 Mar 15; 59(6):568-75. PubMed ID: 16182256
    [Abstract] [Full Text] [Related]

  • 11. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P.
    Synapse; 2006 Dec 01; 60(7):543-52. PubMed ID: 16952163
    [Abstract] [Full Text] [Related]

  • 12. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M, Arango V, Hsiung S, Mann JJ, Underwood MD, Liu K, Kassir SA, Ruggiero DA, Tamir H.
    J Neurosci Res; 2000 Sep 15; 61(6):674-85. PubMed ID: 10972964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M, Coupar IM, Mitchelson FJ.
    Br J Pharmacol; 1999 Jan 15; 126(1):179-88. PubMed ID: 10051134
    [Abstract] [Full Text] [Related]

  • 15. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL, Canton H, Barrett RJ, Sanders-Bush E.
    Pharmacol Biochem Behav; 1998 Nov 15; 61(3):323-30. PubMed ID: 9768567
    [Abstract] [Full Text] [Related]

  • 16. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 2001 Jul 13; 907(1-2):151-5. PubMed ID: 11430898
    [Abstract] [Full Text] [Related]

  • 17. In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics.
    Sánchez C, Arnt J.
    Behav Pharmacol; 2000 Jun 13; 11(3-4):291-8. PubMed ID: 11103883
    [Abstract] [Full Text] [Related]

  • 18. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
    Idris N, Neill J, Grayson B, Bang-Andersen B, Witten LM, Brennum LT, Arnt J.
    Psychopharmacology (Berl); 2010 Jan 13; 208(1):23-36. PubMed ID: 19851757
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.